University of California, Davis

Total Awards: 
33
Approved funds: 
$124,867,313
Major Facility Name: 
Institute for Regenerative cures
Institution type: 
Not for profit

Awards to the Institution

Funding
Disease Team Therapy Development - Research: Nancy Lane Treatment of osteoporosis with endogenous Mesenchymal stem cells $19,999,867
Basic Biology I: Min Zhao Directing migration of human stem cells with electric fields $1,052,715
Research Training II: Frederick Meyers Stem Cell Training Program $7,358,024
Transplantation Immunology: William Murphy Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance $1,317,569
Early Translational II: Roslyn Isseroff Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds $4,640,338
New Faculty II: Paul Knoepfler Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency $2,158,161
New Faculty Physician Scientist: Emanual Maverakis Tunable hydrogels for therapeutic delivery of multipotent stem cells. $3,139,000
Disease Team Therapy Development III: Peter Belafsky Tissue Engineered Recellularized Laryngotracheal Implants $4,440,000
New Faculty I: Chong-Xian Pan Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells $2,567,397
Basic Biology II: Eric Kurzrock Differentiation of Human Embryonic Stem Cells into Urothelium $1,328,400
Early Translational I: Jan Nolta Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders $2,753,559
Early Translational I: Alice Tarantal In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies $4,214,592
Early Translational II: Mark Zern Liver Cell Transplantation $5,199,767
Basic Biology IV: Deborah Lieu Induction of Pluripotent Stem Cell-Derived Pacemaking Cells $1,334,880
Comprehensive Grant: Mark Zern An in vitro and in vivo comparison among three different human hepatic stem cell populations $2,504,614
Comprehensive Grant: Alice Tarantal Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells $2,257,040
Disease Team Therapy Planning I: John Laird Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia $76,861
Disease Team Therapy Planning I: Vicki Wheelock MSC engineered to produce BDNF for the treatment of Huntington's disease $99,248
Disease Team Therapy Planning I: Mehrdad Abedi RUNNING TITLE: Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients $74,195
SEED Grant: Ebenezer Yamoah Hair Cells and Spiral Ganglion Neuron Differentiation from Human Embryonic Stem Cells $469,327
Disease Team Therapy Planning I: Nancy Lane Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis $110,000
SEED Grant: A. Reddi hESCs for Articular Cartilage Regeneration $367,650
Disease Team Therapy Planning I: Martin Birchall Airways for Children $71,218
Training Grant I-1: Frederick Meyers Stem Cell Research Training Grant $2,682,900
Early Translational III: Walter Boyd Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair $4,939,140
Early Translational III: Kyriacos Athanasiou Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells $1,735,703
Disease Team Therapy Development - Research: John Laird Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia $14,184,595
Shared Labs: Alice Tarantal Translational Human Embryonic Stem Cell Shared Research Facility $3,728,111
Disease Team Therapy Development - Research: Vicki Wheelock MSC engineered to produce BDNF for the treatment of Huntington's disease $18,950,061
Tools and Technologies I: Alice Tarantal In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates $842,149
Tools and Technologies I: Kit Lam Discovery of adhesion ligands for pluripotent human stem cells $835,540
Creativity Awards: Gerhard Bauer Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility $264,000
Major Facilities: Larry Vanderhoef No Title $20,082,400
Total:
$135,779,021.00
Icon for xls export

© 2013 California Institute for Regenerative Medicine